Literature DB >> 7511932

Cytokeratin-containing cells in proliferative diabetic retinopathy membranes.

P Hiscott1, R Gray, I Grierson, Z Gregor.   

Abstract

Immunohistochemical techniques were used to investigate the relation between retinal pigment epithelial cells (RPE), traction retinal detachment (TRD) membranes, and combined traction rhegmatogenous retinal detachment (CTR) membranes in proliferative diabetic retinopathy. Seven CTR and five TRD membranes were obtained during closed microsurgery. Six of the seven CTR membranes and one of the five TRD membranes contained RPE. Eleven of the 12 diabetic membranes incorporated glial cells. The findings emphasise that the intravitreal membranes of proliferative diabetic retinopathy contain a diversity of cell types and indicate that RPE tend to contribute to CTR, rather than TRD, membranes. The histopathological appearance of CTR membranes is that of a hybrid between TRD and proliferative vitreo-retinopathy membranes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511932      PMCID: PMC504740          DOI: 10.1136/bjo.78.3.219

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Characterization of glial involvement in proliferative diabetic retinopathy.

Authors:  A Ohira; E de Juan
Journal:  Ophthalmologica       Date:  1990       Impact factor: 3.250

2.  Patterns of cytokeratin and vimentin expression in the human eye.

Authors:  M Kasper; R Moll; P Stosiek; U Karsten
Journal:  Histochemistry       Date:  1988

3.  Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study.

Authors:  P S Hiscott; I Grierson; D McLeod
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

4.  Cytoskeletons of retinal pigment epithelial cells: interspecies differences of expression patterns indicate independence of cell function from the specific complement of cytoskeletal proteins.

Authors:  K Owaribe; J Kartenbeck; E Rungger-Brändle; W W Franke
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

5.  Retinal and epiretinal glia--an immunohistochemical study.

Authors:  P S Hiscott; I Grierson; C J Trombetta; A H Rahi; J Marshall; D McLeod
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

6.  Proliferative vitreoretinopathy membranes. An immunohistochemical study.

Authors:  J A Jerdan; J S Pepose; R G Michels; H Hayashi; S de Bustros; M Sebag; B M Glaser
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

7.  Diabetic preretinal membranes. An immunohistochemical study.

Authors:  J A Jerdan; R G Michels; B M Glaser
Journal:  Arch Ophthalmol       Date:  1986-02

8.  Intravitreal injection of fibroblasts: the pathological effects on the ocular tissues of the rabbit following an intravitreal injection of autologous skin fibroblasts.

Authors:  C A Hitchins; I Grierson
Journal:  Br J Ophthalmol       Date:  1988-07       Impact factor: 4.638

9.  Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy?

Authors:  M Weller; P Esser; K Heimann; P Wiedemann
Journal:  Exp Eye Res       Date:  1991-08       Impact factor: 3.467

10.  The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo.

Authors:  N M McKechnie; M Boulton; H L Robey; F J Savage; I Grierson
Journal:  J Cell Sci       Date:  1988-10       Impact factor: 5.285

View more
  18 in total

1.  Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade.

Authors:  P Hiscott; R M Magee; M Colthurst; N Lois; D Wong
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery.

Authors:  Louisa Wickham; Paris Tranos; Paul Hiscott; David Charteris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-27       Impact factor: 3.117

3.  VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells.

Authors:  B Zhao; A Ma; J Cai; M Boulton
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

4.  Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation.

Authors:  Jeffery L King; Clyde Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

5.  The influence of alloxan-induced diabetes on Müller cell contraction-promoting activities in vitreous.

Authors:  Jeffery L King; John O Mason; Samuel C Cartner; Clyde Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

6.  Isolation and characterization of vitreous insulin-like growth factor binding proteins.

Authors:  Clyde Guidry; Jeffery L King
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

7.  Evaluation of proliferating cell abundance and phenotypes in proliferative diabetic retinopathy.

Authors:  Richard M Feist; Jeffery L King; Richard M Feist; John O Mason; Robert E Morris; Clyde Guidry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-08       Impact factor: 3.117

Review 8.  Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue.

Authors:  Kurt Scavelli; Ayan Chatterjee; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-13       Impact factor: 2.671

9.  Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion.

Authors:  Chi-Ming Chan; Jheng-Hua Huang; Han-Sun Chiang; Wen-Bin Wu; Hsin-Huang Lin; Jing-Yin Hong; Chi-Feng Hung
Journal:  Mol Vis       Date:  2010-04-03       Impact factor: 2.367

10.  Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings.

Authors:  K Li; D Wong; P Hiscott; P Stanga; C Groenewald; J McGalliard
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.